Meeting
2019 Gastrointestinal Cancers Symposium
Excision repair cross-complementing group-1 (ERCC1) gene induction in peripheral blood mononuclear cells as a marker of outcome in patients with colorectal cancer treated with oxaliplatin.
Authors
Devika Rao
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
Devika Rao , Atrayee Basu Mallick , Amartej Merla , Jeeshan Jiffry , Imran Chaudhary , Titto A Augustine , Lakshmi Rajdev , Andreas Kaubisch , Radhashree Maitra , Sanjay Goel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 542)
DOI
10.1200/JCO.2019.37.4_suppl.542
Abstract #
542
Poster Bd #
F5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
The dynamic changes of circulating myeloid-derived suppressor cells (MDSCs) subsets in patients with colorectal cancer undergoing oxaliplatin-based chemotherapy.
First Author: Dilafitria Fauza
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Enrichment of circulating helper-T (Th) and unswitched memory-B (NSwM-B) cell populations and responsiveness to immune checkpoint blockade (ICB) in microsatellite-stable (MSS)/mismatch repair-proficient (pMMR) colorectal cancer (CRC).
First Author: Sebastian Meltzer
Poster
2016 Gastrointestinal Cancers Symposium
Predictive value of ERCC1 and KRAS in colorectal cancer patients with FOLFOX chemotherapy.
First Author: In Kyu Lee
Poster
2016 Gastrointestinal Cancers Symposium
Changes in non-invasive liver fibrosis indices during chemotherapy: Potential marker for oxaliplatin-induced sinusoidal obstruction syndrome.
First Author: Jin-Soo Kim